It is obvious a company’s value is nothing if they do not have patents on their technology. Both MHTX, and AERS have solid patents and definitely worth a mint on it’s own.
“The value of our patented technology is increasing with each new development.” CEO, Manny Tsoupanarias MHTX
This definitely speaks volume and shows just how valuable these patent technologies are in both MHTX and AERS.
MHTX primary patented technology, nanomedicine, is so advanced, it can detect cancer cells 1,000x better than conventional technology.
Manhattan Scientifics acquired the exclusive commercial rights (manufacturing and marketing) to Edward R. Flynn’s (president and CEO of Senior Scientific, LLC) patents and IP in the emerging field of nano medicine; specifically Dr. Flynn’s work in biomagnetic detection of cancer and other diseases through magnetic field sensors. These sensors make it possible to identify and image small clusters of cancer cells substantially increasing the sensitivity for finding cancer at an earlier stage than is currently available, and without the use of ionizing radiation or large magnetic fields.
To learn more about Senior Scientific and the technologies being developed, please visit www.seniorscientific.com. Continue reading →